MDX-1

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMDX-1
Drug Alias Nameanticancer small molecule therapeutic (Suzhou Maidixian Pharmaceutical)MDX-1ZTQ
ClassificationSmall molecules
Mechanisms of ActionRAF serine/threonine protein kinase inhibitorsVascular endothelial growth factor receptor antagonistsAnticancer protein kinase inhibitors
TargetsVascular endothelial growth factor receptorRAF serine/threonine protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSuzhou Maidixian Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuzhou Maidixian Pharmaceutical Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A